- Report
- October 2023
- 226 Pages
Global
From €4421EUR$4,650USD£3,714GBP
== Nanomaterials in Personalized Medicine within Biotechnology ==
Nanomaterials have become a pivotal component of personalized medicine within the biotechnology industry. Personalized medicine, also known as precision medicine, is a medical approach that tailors treatment to the individual characteristics of each patient, considering genetic, environmental, and lifestyle factors. Within this context, nanomaterials – materials with dimensions on the nanoscale – are engineered to exhibit unique properties that can enhance drug delivery systems, diagnostics, and therapeutic procedures. These materials include nanoparticles, nanocomposites, and nanostructured surfaces designed to interact at the molecular level, providing high specificity and efficiency. Their application ranges from targeted drug delivery, where they can carry therapeutic agents directly to diseased cells, to the design of advanced diagnostic tools for the early detection of diseases. The synergy between nanotechnology and personalized medicine holds the promise to revolutionize healthcare by enabling treatments that are custom-designed for individual patients, reducing side effects, and improving outcomes.
=== Companies in the Nanomaterials in Personalized Medicine Market ===
Several companies are actively involved in the development and commercialization of nanomaterials for personalized medicine. Key players include Nanobiotix, which focuses on nanomedicine for cancer treatment; Abraxis Bioscience, a company specializing in nanoparticle drug delivery; and BIND Therapeutics, known for its targeted and programmable therapeutics. Additionally, companies such as Advanced NanoTherapies and MagForce AG are engaged Show Less Read more